Skip to main content
Matthias Tunger Photodesign
01:0

Prof. Dr. med. Dr. h.c. Matthias H. Tschöp

CEO at Helmholtz Munich

"My vision is centered on transformative acceleration from basic research breakthroughs to medical solutions for society."

˝My strategic vision is centered on transformative acceleration of the path from basic research breakthroughs to delivering medical solutions for society.˝

CV
 

Matthias H. Tschöp is the CEO and Spokesperson for the Management at Helmholtz Munich since 2018 and ‘Alexander von Humboldt’ Professor at the Technical University of Munich since 2012. His vision is to position the region Munich as a world leading hub for biomedical research in order to efficiently find new solutions to the health challenges facing our rapidly changing world. He is realizing this by advancing excellence in basic biomedical research and accelerates its translation into personalized prevention and new precision therapies.

Matthias Tschöp (*1967), the physician, scientist and science manager, has made pioneering discoveries in the diabetes and obesity research fields. His achievements include the discovery of the hunger hormone ghrelin as well as the discovery of gut hormone polyagonists, a group of active agents that can significantly improve weight reduction in obesity as well as blood sugar control in type 2 diabetes. The drug Tirzepatide (Mounjaro), produced by Lilly, was the first polyagonist, which was approved for use back in May 2022 (previously in the USA) and another 10 polyagonists are on their way to approval in clinical trials.  

Born in Munich and a family man, he knows the different perspectives between medicine and research from his own experience: After obtaining his license to practice medicine from the Ludwig Maximilian University Hospital, he moved to the United States to work in diabetes research for a pharmaceutical company, co-founded a start-up and headed a research institute at the University of Cincinnati as a professor and research director before returning to Germany after more than ten years abroad. He turned the Helmholtz Diabetes Center into a world-leading research institution as its founding director and launched the Helmholtz Pioneer Campus before he joined the executive board.

Facts and Figures

2020

Member of the European Molecular Biology Organization

2018

CEO at Helmholtz Munich

2018

Full member of the Bavarian Academy of Sciences and Humanities

2017

Honorary Doctor of the University of Leipzig

2016

Member of the Academia Europaea

2013

Member of the Leopoldina

2012

Alexander von Humboldt Professor at the Technical University of Munich

2011

Director Helmholtz Diabetes Center at Helmholtz Munich

2003

Professorship at the University of Cincinnati

1998

Doctorate in Medicine at the Ludwig-Maximilians-Univeristät München

Selected Awards

  • 2021: Ernst Jung Prize for Medicine

  • 2021: Berthold Medal

  • 2019: Paul Langerhans Medal

  • 2017: Carus Medal of the National Academy of Sciences Leopoldina

  • 2016: European Medal of the Society for Endocrinology

  • 2014: Erwin Schrödinger Prize

suppa - stock.adobe.com

Matthias Tschöp Receives Ernst Jung Prize for Medicine 2021

With your consent, third party content may be loaded here, which could use cookies from the respective provider. By using this content, you agree to the use of cookies. You may find more information about cookies in our Privacy Statement.

Twitter feed